- Kroger Health, a unit of Kroger (NYSE:KR), has launched the GLP-1 Complete Support Program for patients using GLP-1 medications for weight management.
- The program offers coordinated access to pharmacists, registered dietitians, clinical services, and personalized nutrition guidance.
- The launch marks an expansion of Kroger's health and wellness services beyond its traditional grocery retail footprint.
Kroger is using its nationwide footprint and health division to offer more integrated services around weight management, an area drawing heightened consumer and medical attention. The GLP-1 Complete Support Program ties pharmacy, nutrition, and clinical support together, which may matter to customers seeking more structure around GLP-1 use. For investors tracking NYSE:KR, it highlights how the company is trying to use existing in-store capabilities to provide more health focused offerings.
As GLP-1 medications remain a focus in weight management treatments, a structured support program could influence how patients choose where to fill prescriptions and seek guidance. For Kroger, the move signals an effort to deepen relationships with health focused shoppers and potentially increase engagement with its pharmacy and nutrition services over time.
Stay updated on the most important news stories for Kroger by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Kroger.
See which insiders are buying and buying and selling Kroger following this latest news.
Quick Assessment
- ✅ Price vs Analyst Target: Kroger trades at US$55.76 versus a consensus target of US$70.64, around 21% below analyst expectations.
- ✅ Simply Wall St Valuation: The stock is flagged as undervalued, trading about 60.7% below one estimate of fair value.
- ❌ Recent Momentum: The share price has declined 2.3% over the past 30 days.
There's only one way to know the right time to buy, sell or hold Kroger. Head to Simply Wall St's company report for the latest analysis of Kroger's Fair Value.
Key Considerations
- 📊 The GLP-1 Complete Support Program shows Kroger using its health platform to provide services around a high profile treatment area, which may deepen customer engagement in its stores and pharmacies.
- 📊 Watch uptake of GLP-1 related services, any commentary on health services revenue and how this aligns with Kroger's current P/E of 32.66 versus the Consumer Retailing industry average of 20.40.
- ⚠️ Kroger has a high level of debt and profit margins of 0.7% that are lower than last year's 1.7%, so added investment in health offerings needs to be assessed alongside balance sheet and margin trends.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Kroger analysis. Alternatively, you can check out the community page for Kroger to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com